Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Environmental Research and Public Health|February 25, 2023
Inequalities in Resource Distribution and Healthcare Service Utilization of Long-Term Care in ChinaChangyong Yang, Jianyuan Huang, Jiahao Yu
Journal of Pharmaceutical Analysis|September 13, 2021
Liquid chromatography-mass spectrometry method for the quantification of an anti-sclerostin monoclonal antibody in cynomolgus monkey serumYuxiong Gao, Zhendong Chen, Changyong Yang, et al.
Materials (Basel, Switzerland)|January 8, 2025
Analysis of Honing Material Removal Rate and Surface Quality Using Electroplated OilstoneHao Su, Changyong Yang, Yucan Fu, et al.
Journal of Evaluation in Clinical Practice|February 13, 2025
Psychometric Properties of Self-Reported Financial Toxicity Measures in Cancer Survivors: An Overview of Systematic ReviewsLeilei Li, Hui Qu, Chaohong Fu, et al.
Molecular Cancer Therapeutics|October 30, 2025
HRA00129-C004, a Novel c-Met Antibody-Drug Conjugate (ADC), Exerts Encouraging Anti-Tumor Activities and Favorable Safety ProfilesYunan Tian, Jieqiong Zhang, Xing Sun, et al.
Cell Death & Disease|October 5, 2018
BMSCs pre-treatment ameliorates inflammation-related tissue destruction in LPS-induced rat DIC modelBiao Wang, Shuming Wu, Zengshan Ma, et al.
Cancer Nursing|December 27, 2024
Digital Interventions for Promoting Skin Self-Examination Behaviors of Melanoma Survivors: A Systematic ReviewLeilei Li, Hui Qu, Chaohong Fu, et al.
Bioanalysis|July 11, 2018
A bridging immunogenicity assay for monoclonal antibody: case study with SHR-1222Dan Zhang, Changyong Yang, Xiaoyan Chen, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 5, 2019
Two validated liquid chromatography-mass spectrometry methods with different pretreatments for the quantification of an anti-CD47 monoclonal antibody in rat and cynomolgus monkey serum compared with an electrochemiluminescence methodYuxiong Gao, Dan Zhang, Changyong Yang, et al.
Molecular Cancer Therapeutics|March 20, 2025
Development of a Tumor-Specific Multivalent CD40 Agonist Antibody FAPxCD40 for Cancer Therapy: Balancing Efficacy and ToxicitySimeng Chen, Yuan Lin, Dan Li, et al.
Pageof 4